首頁 > 市場調查報告書 > 醫療設備

止血劑和組織密封劑市場規模、佔有率和成長分析（按產品、材料、應用、最終用途和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900369

止血劑和組織密封劑市場規模、佔有率和成長分析（按產品、材料、應用、最終用途和地區分類）－2026-2033年產業預測

Hemostasis and Tissue Sealing Agents Market Size, Share, and Growth Analysis, By Product (Topical Hemostats, Adhesive & Tissue Sealant), By Material, By Application, By End-use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球止血和組織密封劑市場規模預計在 2024 年達到 80.1 億美元，從 2025 年的 86.6 億美元成長到 2033 年的 161.5 億美元，在預測期（2026-2033 年）內複合年成長率為 8.1%。

受慢性病增多和人口老化導致的手術需求上升的推動，全球止血劑和組織黏合劑市場正經歷強勁成長。這種不斷成長的需求促使人們尋求能夠提高患者安全並最大限度減少併發症的高效止血和黏合解決方案。外科手術技術的創新，尤其是微創技術的進步，進一步推動了市場擴張，因為患者越來越依賴可靠的藥物來獲得最終療效。製造商正優先投入研發，開發療效更佳、副作用更小的先進產品，以提高其在醫療專業人員中的認可度。然而，嚴格的法規結構、成本限制和競爭壓力等挑戰仍然影響著市場動態和盈利，因此需要持續投資於創新和策略定位。

全球止血劑和組織密封劑市場促進因素

微創手術技術的日益普及顯著增加了對專用止血劑和組織封裝的需求，尤其是在腹腔鏡、內視鏡和機器人輔助手術中。這些藥物對於有效止血和確保組織牢固閉合至關重要，有助於改善手術效果和促進患者康復。隨著醫療專業人員不斷採用這些先進的手術技術，對輔助手術的創新解決方案的需求也在不斷成長，從而推動了止血劑和組織黏合劑市場的發展。這一趨勢反映了現代醫學中提高手術效率和病人安全性的更廣泛追求。

限制全球止血劑和組織黏合劑市場的因素

新型止血劑和組織黏合劑的市場准入往往受到漫長而高成本的核准流程的阻礙，這主要是由於嚴格的監管要求。這些嚴格的通訊協定為生產商帶來了巨大的挑戰，並延緩了創新產品的商業化。因此，新型產品更難通過複雜的監管程序並獲得市場認可，最終抑制了競爭，限制了醫療服務提供者和患者的選擇。這可能會對全球止血劑和組織黏合劑市場的整體成長產生負面影響。

全球止血劑和組織密封劑市場趨勢

全球止血和組織黏合劑市場正日益受到微創手術技術顯著發展的推動。這一趨勢源自於微創手術的許多優勢，例如切口更小、疤痕更少、恢復更快。隨著醫療專業人員採用這些先進技術，對專業止血和組織密封解決方案的需求爆炸性成長，從而推動了產品研發的創新。對患者療效的日益關注，以及材料和技術的進步，正在重塑市場格局，並催生出更多針對微創手術特定需求的有效密封劑產品組合。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Johnson & Johnson（United States）
Baxter International Inc.（United States）
Pfizer Inc.（United States）
Integra LifeSciences Corporation（United States）
Smith & Nephew plc（United Kingdom）
B. Braun Melsungen AG（Germany）
CryoLife, Inc.（United States）
CSL Behring（Australia）
Medtronic plc（Ireland）
Zimmer Biomet Holdings, Inc.（United States）
Ferrosan Medical Devices A/S（Denmark）
Cohera Medical, Inc.（United States）
Marine Polymer Technologies, Inc.（United States）
Equimedical BV（Netherlands）
Advanced Medical Solutions Group plc（United Kingdom）
Cohesion Technologies, Inc.（United States）
HyperBranch Medical Technology, Inc.（United States）
Terumo Corporation（Japan）
Mil Laboratories Pvt. Ltd.（India）

結論與建議

簡介目錄

Product Code: SQMIG35A2694

Global Hemostasis and Tissue Sealing Agents Market size was valued at USD 8.01 Billion in 2024 and is poised to grow from USD 8.66 Billion in 2025 to USD 16.15 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The global market for hemostasis and tissue sealing agents is witnessing robust growth, fueled by the increasing incidence of chronic diseases and a rising elderly population, leading to heightened surgical demands. This surge necessitates effective hemostatic and sealing solutions to enhance patient safety and minimize complications. Innovations in surgical procedures, particularly minimally invasive techniques, further stimulate market expansion, with a growing dependence on reliable agents to secure successful outcomes. Manufacturers are prioritizing research and development to create advanced products with enhanced efficacy and fewer side effects, fostering greater acceptance among healthcare professionals. However, challenges persist, including stringent regulatory frameworks, cost constraints, and competitive pressures that impact market dynamics and profitability, necessitating ongoing investment in innovation and strategic positioning.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemostasis and Tissue Sealing Agents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemostasis and Tissue Sealing Agents Market Segments Analysis

Global Hemostasis and Tissue Sealing Agents Market is segmented by Product, Material, Application, End-use and region. Based on Product, the market is segmented into Topical Hemostats and Adhesive & Tissue Sealant. Based on Material, the market is segmented into Gelatin-based Topical Hemostats, Collagen-based Topical Hemostats, ORC-based Topical Hemostats and Polysaccharide-based Topical Hemostats. Based on Application, the market is segmented into General Surgery,Neurosurgery, Vascular Surgery, Cardiovascular Surgery and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Home Care Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hemostasis and Tissue Sealing Agents Market

The increasing inclination towards minimally invasive surgical methods has significantly elevated the need for specialized hemostatic and tissue sealing agents, particularly in laparoscopic, endoscopic, and robotic-assisted surgeries. These agents are essential for achieving effective hemostasis and ensuring secure tissue closure, thus enhancing surgical outcomes and patient recovery. As healthcare professionals continue to adopt these advanced surgical techniques, the demand for innovative solutions that support these procedures intensifies, driving the growth of the market for hemostatic and tissue sealing agents. This trend reflects a broader movement towards improving surgical efficiency and patient safety in modern medical practices.

Restraints in the Global Hemostasis and Tissue Sealing Agents Market

The entry of new hemostasis and tissue sealing agents into the market is often impeded by a lengthy and costly approval process, largely driven by stringent regulatory requirements. These rigorous protocols can pose significant challenges for manufacturers, resulting in delays in the commercialization of innovative products. Consequently, the potential for new agents to gain market traction is diminished as they navigate complex regulations, ultimately stifling competition and limiting options for healthcare providers and patients alike. As a result, the overall growth of the global hemostasis and tissue sealing agents market may be adversely affected.

Market Trends of the Global Hemostasis and Tissue Sealing Agents Market

The Global Hemostasis and Tissue Sealing Agents market is increasingly driven by a pronounced shift towards minimally invasive surgical techniques. This trend is propelled by the numerous benefits associated with such procedures, including smaller incisions, reduced scarring, and expedited recovery times. As medical professionals adopt these advanced techniques, the necessity for specialized hemostasis and tissue sealing solutions has surged, fostering innovation in product development. The growing emphasis on patient outcomes, coupled with advancements in materials and technologies, is reshaping the market landscape, resulting in an expanded portfolio of effective sealing agents tailored to the specific needs of minimally invasive surgeries.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Raw Material Analysis

Global Hemostasis and Tissue Sealing Agents Market Size by Product & CAGR (2026-2033)

Market Overview
Topical Hemostats
- Active
- Mechanical
- Flowable
Adhesive & Tissue Sealant
- Synthetic Tissue Sealant
- Natural Tissue Sealant
- Adhesion Barrier Products

Global Hemostasis and Tissue Sealing Agents Market Size by Material & CAGR (2026-2033)

Market Overview
Gelatin-based Topical Hemostats
Collagen-based Topical Hemostats
ORC-based Topical Hemostats
Polysaccharide-based Topical Hemostats

Global Hemostasis and Tissue Sealing Agents Market Size by Application & CAGR (2026-2033)

Market Overview
General Surgery
Neurosurgery
Vascular Surgery
Cardiovascular Surgery
Others

Global Hemostasis and Tissue Sealing Agents Market Size by End-use & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory Surgical Centers
Home Care Settings
Others

Global Hemostasis and Tissue Sealing Agents Market Size & CAGR (2026-2033)

North America (Product, Material, Application, End-use)
- US
- Canada
Europe (Product, Material, Application, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Material, Application, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Material, Application, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Material, Application, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CryoLife, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CSL Behring (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferrosan Medical Devices A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cohera Medical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Marine Polymer Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Equimedical B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Medical Solutions Group plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cohesion Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HyperBranch Medical Technology, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mil Laboratories Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments